BTIG Reiterates Buy Rating on Verastem, Keeps $24 Price Target
BTIG reiterated its Buy rating and $24.00 price target on Verastem. The target implies 177.5% upside from the Oct. 16 close of $8.65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.